Promising Alzheimer’s drug posdinemab gets FDA fast-track status
Drug Target Review - 04-Feb-2025In Phase IIb trials, plasma biomarkers identify early-stage patients
Alzheimer's Disease
Alzheimer's Disease News
Arctic Therapeutics secures €26.5M to advance dementia drugs
Longevity Technology - 21-Jan-2025Early trials show reduced stroke risks and slower progression
Visceral fat could predict Alzheimer’s decades before symptoms
Independent - 02-Dec-2024Excess internal fat may signal early brain changes linked to Alzheimer’s
Abbvie’s $1.4b bet on alzheimer’s biotech Aliada
Longevity Technology - 29-Oct-2024Aliada’s BBB technology aims to transform CNS drug delivery
NHS rejects funding for new Alzheimer's drug due to small benefit, high cost
BBC - 23-Oct-2024The drug 'donanemab' remains available for private treatment in England
Alzheimer's Disease Resources
Click on resource name for more details.
The End of Alzheimer’s Program
The First Protocol to Enhance Cognition and Reverse Decline at Any Age written by Dale Bredesen
ALZHEIMER’S STUDY: Lifestyle Changes & Early Alzheimer’s Disease
Dean Ornish highlights how simple lifestyle changes can reverse chronic diseases
Neurobiology of Alzheimer’s disease
Book that covers all major aspects of the disease from basic science to clinical diagnosis and therapy edited by David Dawbarn
The Dementias 2: Blue Books of Neurology Series
Provides rapid access to practical, clinical guidance on the diagnosis and treatment of all forms of dementia edited by John H. Growdon
Neurodegenerative Diseases: Neurobiology, Pathogenesis and Therapeutics
Book about neurodegenerative diseases edited by Flint Beal
Alzheimer's Disease Blog Posts
No blog posts found!
